Arrowhead Creates Hepatitis B Clinical Advisory Board And Names Dr. Robert Gish Chairman
Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, announced today that prominent hepatologist Robert G. Gish, MD, will serve as Chairman of the company’s newly created hepatitis B Clinical Advisory Board. In this leadership role, Dr. Gish will assist with recruitment of additional advisory board members and will advise the company on clinical and regulatory approval strategy in addition to analysis, and interpretation of clinical trial results for the HBV program and its associated lead candidate, ARC-520.
“Hepatitis B is a global problem that needs more effective treatment options,” said Dr. Gish. “Arrowhead’s clinical candidate, ARC-520 is a unique and potentially powerful approach to treating HBV and I’m excited to have the opportunity to contribute to this clinical program.”
“Dr. Gish’s international expertise in hepatitis B and his guidance on clinical trials both in the U.S. and in Asia are important to Arrowhead,” said Dr. Chris Anzalone, President and CEO of Arrowhead. “We are honored to have somebody of his caliber chair our Clinical Advisory Board.”
Dr. Gish joined the full time faculty at University of California, San Diego in December 2010 as Clinical Professor, Section Chief of Hepatology, and Medical Director for the Center of Excellence for Hepatobiliary Disease and Abdominal Transplantation (CHAT). Since that date, research efforts have expanded to include Point of Care testing, public policy for viral hepatitis, collaboration with co-investigators to study NASH, metabolism of intralipid infusions and clinical trials for HCV and HBV.
He was the Co-Medical Director at the California Pacific Medical Center in San Francisco and became the Medical Director of the Liver Transplant Program in 1995. He was a faculty member at the University of California, Davis from 1991-1994 and was also part of the faculty at the Merced Family Practice Program (UCD affiliate) from 1991 to 1999. Dr. Gish rose to the rank of a Clinical Professor position at the University of California, San Francisco in 2009 and a Clinical Professor position at the University of Nevada, Reno and Las Vegas in 2006.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
